| Name | Osceola Vision Center Pc |
|---|---|
| Organization Name | Osceola Vision Center Pc |
| Location | 816 Albia Rd., Ottumwa, Iowa 52501 |
| Type | Eyewear Supplier (Equipment, not the service) |
| Phone | (641) 682-9816 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Agence France-Presse examines the ongoing fight to control the spread of tuberculosis in South Africa. "The World Health Organisation estimates almost one percent or 461,000 South Africans develop TB annually, with government figures showing that the disease was the country's leading natural cause of death in 2006," the news service writes.
Wolters Kluwer Health today announced that it has acquired Medknow PVT Ltd., a leading Scientific, Technical & Medical (STM) journal publishing operation headquartered in Mumbai, India and one of the largest open access publishers in the world.
Nektar Therapeutics reported today that partner Baxter International Inc. announced that the company has submitted a new drug application (NDA) to Japan's Ministry of Health, Labour and Welfare for the approval of BAX 855, an investigational, extended half-life recombinant factor VIII (rFVIII) treatment based on ADVATE [Antihemophilic Factor (Recombinant)] for patients over 12 years of age with hemophilia A.
Prana Biotechnology today announced the successful completion of Reach2HD, a phase 2 clinical trial in patients with early to mid-stage Huntington disease. The Company expects to announce the results arising from the trial in October.
"Large sums of public money intended to ensure children in the developing world are immunized against disease are effectively being used to subsidize Big Pharma, doctors working in the field claim," the Guardian reports.
› Verified 8 days ago
| NPI Number | 1245416155 |
| Organization Name | OSCEOLA VISION CENTER P.C. |
| Doing Business As | OTTUMWA EYE CARE |
| Type | Eyewear Supplier (Equipment, not the service) |
| Address | 103 W Main St, Ottumwa, IA 52501 |
| Phone Number | 641-682-9816 |
News Archive
Agence France-Presse examines the ongoing fight to control the spread of tuberculosis in South Africa. "The World Health Organisation estimates almost one percent or 461,000 South Africans develop TB annually, with government figures showing that the disease was the country's leading natural cause of death in 2006," the news service writes.
Wolters Kluwer Health today announced that it has acquired Medknow PVT Ltd., a leading Scientific, Technical & Medical (STM) journal publishing operation headquartered in Mumbai, India and one of the largest open access publishers in the world.
Nektar Therapeutics reported today that partner Baxter International Inc. announced that the company has submitted a new drug application (NDA) to Japan's Ministry of Health, Labour and Welfare for the approval of BAX 855, an investigational, extended half-life recombinant factor VIII (rFVIII) treatment based on ADVATE [Antihemophilic Factor (Recombinant)] for patients over 12 years of age with hemophilia A.
Prana Biotechnology today announced the successful completion of Reach2HD, a phase 2 clinical trial in patients with early to mid-stage Huntington disease. The Company expects to announce the results arising from the trial in October.
"Large sums of public money intended to ensure children in the developing world are immunized against disease are effectively being used to subsidize Big Pharma, doctors working in the field claim," the Guardian reports.
› Verified 8 days ago
News Archive
Agence France-Presse examines the ongoing fight to control the spread of tuberculosis in South Africa. "The World Health Organisation estimates almost one percent or 461,000 South Africans develop TB annually, with government figures showing that the disease was the country's leading natural cause of death in 2006," the news service writes.
Wolters Kluwer Health today announced that it has acquired Medknow PVT Ltd., a leading Scientific, Technical & Medical (STM) journal publishing operation headquartered in Mumbai, India and one of the largest open access publishers in the world.
Nektar Therapeutics reported today that partner Baxter International Inc. announced that the company has submitted a new drug application (NDA) to Japan's Ministry of Health, Labour and Welfare for the approval of BAX 855, an investigational, extended half-life recombinant factor VIII (rFVIII) treatment based on ADVATE [Antihemophilic Factor (Recombinant)] for patients over 12 years of age with hemophilia A.
Prana Biotechnology today announced the successful completion of Reach2HD, a phase 2 clinical trial in patients with early to mid-stage Huntington disease. The Company expects to announce the results arising from the trial in October.
"Large sums of public money intended to ensure children in the developing world are immunized against disease are effectively being used to subsidize Big Pharma, doctors working in the field claim," the Guardian reports.
› Verified 8 days ago
American Homepatient Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2604 N Court St, Ottumwa, Iowa 52501 Phone: (641) 682-8555 | |
J. Brent Altfillisch Od Pc Type: Medicare Supplier Location: 224 E Main St, Ottumwa, Iowa 52501 Phone: (641) 684-5463 | |
Eye Care Optical Llc Type: Eyewear Supplier (Equipment, not the service) Location: 1005 Pennsylvania Ave, Ottumwa, Iowa 52501 Phone: (641) 682-8571 | |
Hammer Incorporated Type: Durable Medical Equipment & Medical Supplies Supplier Location: 613 E Pennsylvania Ave, Ottumwa, Iowa 52501 Phone: (641) 684-6800 | |
Hy-vee Drugstore 7065 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1140 N Jefferson St, Ottumwa, Iowa 52501 Phone: (641) 684-5467 |